A hybridoma is selected that produces a monoclonal antibody exhibiting high reactivity to soluble hepatocyte growth factor activator inhibitor-1 (soluble HAI-1), the target monoclonal antibody is prepared from culture supernatant of the obtained hybridoma, and by using the antibody soluble HAI-1 is measured.

 
Web www.patentalert.com

< Laminated sheets for use in a fully retrievable occlusion device

< Apparatus for relieving the symptoms of deep vein thrombosis

> Device and method for modifying the shape of a body organ

> Compositions and methods for producing vascular occlusion using a solid-phase platelet binding agent
~ 00280